Xuebin Wang
355 Luding Road
Putuo, China
Putuo, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Timing matters: tacrolimus intra-patient variability within the initial seven months forecasts de novo DSA and subsequent rejection in a Chinese kidney transplant cohort.
Journal: Frontiers in immunology
Published: February 11, 2026
ABCC2 rs2273697 is an independent determinant of tacrolimus intra-patient variability during the first year after kidney transplantation.
Journal: International journal of clinical pharmacy
Published: December 18, 2025
Comparing tacrolimus level monitoring in peripheral blood mononuclear cells and whole blood within one year after kidney transplantation: a single-center, prospective, observational study.
Journal: Frontiers in pharmacology
Published: May 04, 2025
Simultaneously blocking ANGPTL3 and IL-1β for the treatment of atherosclerosis through lipid-lowering and anti-inflammation.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: July 04, 2024
Impact of intra-patient variability of tacrolimus on allograft function and CD4 + /CD8 + ratio in kidney transplant recipients: a retrospective single-center study.
Journal: International journal of clinical pharmacy
Published: February 06, 2024
Tacrolimus intra-patient variability measures and its associations with allograft clinical outcomes in kidney transplantation.
Journal: Transplantation reviews (Orlando, Fla.)
Published: December 11, 2023
Wuzhi Capsule Dosage Affects Tacrolimus Elimination in Adult Kidney Transplant Recipients, as Determined by a Population Pharmacokinetics Analysis.
Journal: Pharmacogenomics and personalized medicine
Published: May 26, 2021
Switching Immunosuppression From Cyclosporine to Tacrolimus in Kidney Transplant Recipients Based on CYP3A5 Genotyping.
Journal: Therapeutic drug monitoring
Published: December 07, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026